IASO-782 in Autoimmune Hematological Diseases

Clinical trial NCT06534021 · RECRUITING

Trial details

NCT number: NCT06534021
Sponsor: Shanghai IASO Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Thrombocytopenia Warm Autoimmune Haemolytic Anaemia

Start date: 2024-08-08
Primary completion: 2027-10-09
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.